US State Peptide Laws & Regulations

Peptide regulations in the United States are primarily governed by federal law (FDA), but individual states may have additional requirements through their Boards of Pharmacy, health departments, or specific legislation.

Note: Most peptide regulation occurs at the federal level through the FDA. State variations primarily affect pharmacy compounding, dispensing requirements, and enforcement priorities. Always verify current regulations with state authorities.

State-by-State Overview

State	Status	Summary
Alabama	Gray Area	Follows federal guidelines. No specific state peptide regulations.
Alaska	Gray Area	Limited state-level regulation. Federal rules apply.
Arizona	Gray Area	Active wellness market. Pharmacy board oversight for compounding.
Arkansas	Gray Area	Standard federal compliance required.
California	Restricted	Stricter pharmacy regulations. Board of Pharmacy active enforcement.
Colorado	Gray Area	Generally follows federal guidelines.
Connecticut	Restricted	Pharmacy board has specific compounding requirements.
Delaware	Gray Area	Federal regulations primarily apply.
Florida	Gray Area	Large peptide market. Recent legislative activity on research chemical sales.
Georgia	Gray Area	Federal guidelines apply. No specific state peptide laws.
Hawaii	Restricted	Import restrictions may apply due to island location.
Idaho	Gray Area	Limited state regulation beyond federal requirements.
Illinois	Gray Area	Standard federal compliance. Chicago has active enforcement.
Indiana	Gray Area	Follows federal guidelines primarily.
Iowa	Gray Area	No specific state peptide regulations.
Kansas	Gray Area	Federal rules apply. Limited state oversight.
Kentucky	Gray Area	Standard regulatory environment.
Louisiana	Gray Area	Pharmacy board has compounding oversight.
Maine	Gray Area	Limited specific peptide regulations.
Maryland	Restricted	Board of Pharmacy has enhanced oversight.
Massachusetts	Restricted	Stricter compounding regulations post-NECC incident.
Michigan	Gray Area	Federal guidelines primarily apply.
Minnesota	Gray Area	Standard regulatory framework.
Mississippi	Gray Area	Limited state-level peptide regulation.
Missouri	Gray Area	Generally follows federal guidelines.
Montana	Gray Area	Limited regulatory oversight.
Nebraska	Gray Area	Federal regulations apply.
Nevada	Gray Area	Wellness industry present. Standard oversight.
New Hampshire	Gray Area	Limited state regulation.
New Jersey	Restricted	Board of Pharmacy active in compounding oversight.
New Mexico	Gray Area	Standard federal compliance required.
New York	Restricted	Department of Health has enhanced oversight. Stricter compounding rules.
North Carolina	Gray Area	Follows federal guidelines.
North Dakota	Gray Area	Limited state-specific regulation.
Ohio	Gray Area	Pharmacy board oversight. Federal rules apply.
Oklahoma	Gray Area	Standard regulatory environment.
Oregon	Gray Area	Generally follows federal guidelines.
Pennsylvania	Gray Area	Pharmacy board has compounding regulations.
Rhode Island	Restricted	Enhanced pharmacy oversight.
South Carolina	Gray Area	Federal regulations primarily apply.
South Dakota	Gray Area	Limited state regulation.
Tennessee	Gray Area	Standard federal compliance.
Texas	Gray Area	Large market. AG office has issued guidance on research peptide sales.
Utah	Gray Area	Supplement industry hub. Standard peptide regulation.
Vermont	Gray Area	Limited state-specific rules.
Virginia	Gray Area	Pharmacy board oversight. Federal rules apply.
Washington	Gray Area	Department of Health has pharmacy oversight.
West Virginia	Gray Area	Standard regulatory framework.
Wisconsin	Gray Area	Follows federal guidelines.
Wyoming	Gray Area	Limited state regulation.

Understanding State vs Federal Regulation

Federal Authority (FDA)

The FDA has primary authority over drug regulation, including peptides. Key federal regulations include:

Drug approval requirements under the FD&C Act
Compounding pharmacy oversight (503A and 503B)
Import/export controls
Labeling and marketing requirements

State Authority

States primarily regulate through:

Boards of Pharmacy: Licensing, compounding standards, dispensing rules
Health Departments: Public health oversight, clinic regulations
Attorney General: Consumer protection enforcement
Legislature: State-specific controlled substance schedules

Key Differences by State

State variations typically affect:

Compounding pharmacy requirements and inspections
Telemedicine and telehealth prescribing rules
Enforcement priorities and resources
State-scheduled controlled substances (beyond federal DEA schedules)

View US Federal Laws FDA Updates